Abivax is a French listed, late-stage clinical biotech company mobilizing the body’s natural immune system machinery to treat patients with inflammatory diseases, viral infections and cancer

Abivax leverages its immune enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis, Crohn’s disease, Rheumatoid Arthritis, and other inflammatory diseases (ABX464), Covid-19 (ABX464), HIV (ABX464), and liver cancer (ABX196)

Abivax was founded by Truffle Capital and is now backed by Sofinnova and Santé Holding, as well as Vivo Capital, Perceptive, Invus, Commodore, and LSP

Capital raise proceeds will be mainly used for the launch and continuation of the clinical programs of ABX 464, the Company’s lead product in advanced development, financing of R&D and working capital and other general purposes of the Company; redemption of (and payment of amounts payable pursuant to) existing indebtedness; advancement of the phase 1/2 proof-of-concept clinical trial of ABX196 for the treatment of hepatocellular carcinoma

About Abivax

Abivax, a clinical stage biotechnology company, is developing novel therapies that modulate the physiological inflammation and immunological pathways to treat patients with chronic inflammatory diseases, viral infections, and cancer. Abivax is listed on Euronext compartment B (ISIN: FR0012333284 – Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma.

Discover Abivax

Olivier Garnier

Investment Banking

Olivier Garnier senior photo

Pierre Kiecolt-Wahl

Equity Capital Markets

Pierre Kiecolt-Wahl senior photo

Clifford Siegel

Investment Banking

Cosme Rosellini

Equity Capital Markets

Cosme Rosellini photo

Will Jungman

Investment Banking

Théodore de Charsonville

Equity Capital Markets

Théodore De Charsonville photo

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }